Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Central Centrifugal Cicatricial Alopecia
NCT06998433Phase 4Not yet recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2025
- Primary completion
- Jul 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of platelet-rich plasma in central centrifugal cicatricial alopecia (CCCA), sponsored by Baylor College of Medicine. Primary endpoint: Physician Global Assessment of Regrowth. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
central centrifugal cicatricial alopecia (CCCA)
Beyond the preview
Go deeper on NCT06998433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06998433.